New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
Home > Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings, Inc.
Industry: Life Sciences ・ $HRMY on Nasdaq ・ Market Cap: Small
Top Executive Recent Sales
1Y INSIDER TRADING ACTIVITY
Insider Trade Volume in USD
1Y INSIDER ACTIVITY
| TRADES PURCHASE/SALE Sector Average | 0 / 9 2.19 / 7.65 |
| INSIDER BUYERS/SELLERS Sector Average | 0 / 2 1.2 / 2.5 |
| SHARES PURCHASED/SOLD Transaction Average | 0 / 4,718,000 0 / 524,222 |
| VALUE PURCHASED/SOLD Transaction Average | $0 / $143,921,664 $0 / $15,991,296 |
| PURCHASE RANGE | N/A |
| SALE RANGE | $6,208 - $139,380,000 |
INSIDER PERFORMANCE OVERVIEW
PURCHASE PERFORMANCE
0 / 8
CEO Purchases
Top Executive Purchases
New Purchase Insider
High Purchase Reporters Count
High Purchase Activity
Regular Purchase Insiders
Abnormal High-Volume Purchases
High Purchases Frequency
SALE PERFORMANCE
1 / 4
CEO Sales
Top Executive Sales
Regular Sale Insiders
High Sales Frequency
1Y PURCHASE DISTRIBUTION
purchase distribution by individual insiders
No Insider Trades made
0%
DIRECTORS
0%
OFFICERS
0%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | N/A 0.2 |
VALUE GINI INDEX Sector Average | N/A 0.206 |
1Y SALE DISTRIBUTION
sale distribution by individual insiders
0%
DIRECTORS
2.5%
OFFICERS
97.5%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | 0.468 0.295 |
VALUE GINI INDEX Sector Average | 0.475 0.288 |
Harmony Biosciences Holdings, Inc. 1Y Trade Transactions
Submission Date Period of Report | Insider | Position | Total Value | Shares | Share Price | Ownership % Change | Shares Owned | Post Day Stock Change | Post Week Stock Change | |
|---|---|---|---|---|---|---|---|---|---|---|
2025-01-21 2025-01-16 | Dierks Jeffrey | Officer | -$1,184,449 | 30,598 | $38.71 | -100% | 0 | N/A | N/A | |
2025-01-16 2025-01-15 | Dierks Jeffrey | Officer | -$388,864 | 10,507 | $37.01 | -100% | 0 | +4.57% | N/A | |
2025-01-15 2025-01-13 | Dierks Jeffrey | Officer | -$265,947 | 7,180 | $37.04 | -100% | 0 | +4.36% | N/A | |
2024-11-05 2024-11-01 | Valor IV Pharma Holdings, LLC | 10% Owner | -$139,380,000 | 4,600,000 | $30.3 | -41.01% | 6,618,033 | +4.49% | -1.23% | |
2024-10-31 2024-10-29 | Dierks Jeffrey | Officer | -$869,943 | 21,496 | $40.47 | -100% | 0 | +2.86% | +8.65% | |
2024-10-01 2024-09-30 | Dierks Jeffrey | Officer | -$1,434,915 | 35,846 | $40.03 | -100% | 0 | -10.93% | -10.93% | |
2024-09-30 2024-09-27 | Dierks Jeffrey | Officer | -$8,010 | 200 | $40.05 | -100% | 0 | -1.90% | -12.62% | |
2024-03-18 2024-03-15 | Dierks Jeffrey | Officer | -$383,328 | 11,979 | $32 | -100% | 0 | +2.09% | +3.20% | |
2024-03-11 2024-03-08 | Dierks Jeffrey | Officer | -$6,208 | 194 | $32 | -100% | 0 | -1.17% | +2.63% |